Eye on AI: Applying Artificial Intelligence to Drive Cancer Research, Part 2
Researchers highlighted AI's potential to enhance clinical cancer care, including to improve diagnosis, guide precision medicine, and more.
Progress Against Cancer
Researchers highlighted AI's potential to enhance clinical cancer care, including to improve diagnosis, guide precision medicine, and more.
New clinical trials are exploring an array of CAR T-cell approaches for children with cancers of the brain and spinal cord.
Preliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.
The AACR hosted a Virtual Patient Advocate Forum in July 2025 on technology’s role in cancer care.
Potential new approach to treating diffuse intrinsic pontine glioma uses engineered immune cells infused directly to the brain.
Researchers highlighted AI's potential to enhance cancer research, including to discover cancer drivers and new therapeutic opportunities.
Researchers are exploring which cancer types have higher incidence in people under 50, what may be causing this rise of early-onset cancers.
This month, the AACR's journals editors highlighted studies on U.S. cancer mortality hotspots, chemotherapy-induced hearing loss, and more.
Advances in cardio-oncology are redefining cancer care, shaping safer treatments to protecting patients’ hearts.
This post examines ultraprocessed foods and what current research shows about how they impact health and cancer risk.
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn More